Home › Products › Oncology › Olparib 150mg Tablet
Olparib 150mg Tablet
Salt Composition: OLAPARIB
- Manufacturer: GLENMARK PHARMACEUTICALS LTD
- Pack Size: 60 TABLET(s) IN A BOTTLE
- Dosage Form: TABLET
- Strength: 150MG
- Prescription Required
- Storage: Store Olparib 150mg Tablet in the original package at room temperature (20°C to 25°C). Keep it out of reach from children.
₹9499.00₹13232.34
Inclusive of all taxes
Product Introduction
Olparib 150mg Tablet contains the active ingredient Olaparib, a PARP inhibitor indicated for treatment of ovarian, pancreatic, and prostate cancers. It functions by inhibiting repair mechanisms in cancer cell DNA, thereby slowing disease progression. The 150mg dosage for ovarian cancer is determined by your doctor based on your clinical condition. Do not use this medicine if you are allergic to any of its components. Regular blood tests are necessary as the medication may reduce blood cell counts. Avoid use during pregnancy or while breastfeeding. Effective contraception is advised during treatment and afterwards. Inform your doctor of all other medications you are taking to avoid potential interactions. This tablet is manufactured to established quality standards and efficacy requirements. Patients with access to this medicine can check pricing at pharmacies or obtain it through authorised online healthcare platforms. If this formulation is unavailable, your doctor may recommend an alternative olaparib preparation. Patient experiences with Olparib 150mg Tablet are available for reference.
Uses
Olparib 150mg uses are Treatment of Prostate cancer Metastatic Pancreatic cancer
How it works
Olparib 150mg Tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Olparib 150mg Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
How to Use
The medicine will be prescribed to you by a healthcare professional in a hospital setting. Olparib 150mg Tablet is available as a tablet to be taken with or without food, as directed by your healthcare provider. The dose will be decided by your healthcare professional based on your conditions. Avoid crushing, opening, or dissolving the tablet and swallow it whole with a glass of water. Take the Olparib 150mg Tablet at the same time every day.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common Shortness of breath Nausea Vomiting Fatigue Dyspepsia Loss of appetite Dizziness Diarrhoea Headache Serious Neutropenia Acute myeloid leukemia Leukopenia Thrombocytopenia Lung problems
References
- Lynparza, United States Food and Drug Administration (USFDA), [Revised on May 2020], [Accessed on March 2024], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208558s014lbl.pdf
- AstraZeneca UK Limited, European Medicines Compendium (emc), [Revised on August 2023], [Accessed on March 2024], https://www.medicines.org.uk/emc/files/pil.9204.pdf
- AstraZeneca Pharmaceuticals LP, [Revised on November 2023], [Accessed on March 2024], https://den8dhaj6zs0e.cloudfront.net/50fd68b9-106b-4550-b5d0-12b045f8b184/00997c3f-5912-486f-a7db-930b4639cd51/00997c3f-5912-486f-a7db-930b4639cd51_viewable_rendition__v.pdf
Safety Advice
Pregnancy: unsafe It is not recommended to take Olparib 150mg Tablet during pregnancy as it may harm your unborn baby. It is necessary to inform your doctor if you are pregnant or planning to become pregnant.
Lungs: Consult your doctor Consult your doctor if you have any lung diseases before starting the treatment with Olparib 150mg Tablet.
Breastfeeding: unsafe It is unknown whether Olparib 150mg Tablet passes into the breast milk. It is not recommended to nurse a child during and after 1 month of completion of therapy. Please consult your doctor before breastfeeding.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.